Special Issue "Antiviral Peptides - From Discovery to Translation"
A special issue of Biologics (ISSN 2673-8449).
Deadline for manuscript submissions: 30 June 2022.
Interests: antimicrobial peptides; anti-fungal peptides; anticancer peptides; MDR Pseudomonas aeruginosa; MRSA; MDR E. coli; VRE; peptide libraries; SPOT synthesis
Special Issues, Collections and Topics in MDPI journals
The current COVID-19 pandemic illustrates the impact a viral infection can have on our society and on our way of life. There are only a few antivirals available and vaccination is often, where possible, the best way to address viral infections. More research in antiviral drugs is urgently needed also in the sight of possible new crossovers of viruses from the animal kingdom to humans. A rich source to study and develop antiviral molecules are antiviral peptides (AVPs). There are currently 2683 antiviral peptides stored in the antiviral peptide database AVPdb. In addition, several antiviral peptides against SARS-CoV-2 are in clinical trials showing the potential of this class of molecules.
We are inviting manuscripts on all aspects of antiviral peptides, from discovery to translation. We are looking for original research and reviews. These can be screening, identification, characterization, mode of action, toxicity, efficacy, pharmacodynamics, and application in humans or animals.
Dr. Kai Hilpert
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biologics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Antiviral peptides
- Antiviral compounds
- Antimicrobial peptides
- Drug discovery
- Drug development
- Infectious disease
- Viral infection
- Pathogenic virus for humans
- Pathogenic virus for animals